Stand Up To Cancer, also known as SU2C, is a privately owned organization based in the United States. Founded in 2008, it employs approximately 60 individuals. Its primary focus is entertainment content rights. The organization's mission centers on raising funds to accelerate translational research, aiming to facilitate the delivery of new therapies to patients.
On October 1, 2026, research indicated that high bacteria levels in tumors could enhance the effectiveness of immune-based treatments, building on findings that the gut microbiome influences how well certain cancer treatments work. Previously, on September 21, a Phase 2 trial suggested that vitamin C may benefit individuals with pre-cancer blood disorders. This research explores whether restoring chronically low vitamin C levels, common in people with pre-cancer blood disorders and blood cancer, could improve patient outcomes. Earlier, on August 13, American Airlines, in collaboration with Stand Up To Cancer and Lily Collins, launched its 10th annual campaign to raise funds for innovative cancer research, seeking customer support for the initiative.
Similar Companies
Subscribe for full access to Stand Up To Cancer's profile
Stand Up To Cancer offers products in the media and telecoms services industry. Stand Up To Cancer's product portfolio comprises of entertainment content rights.
Subscribe for full access to Stand Up To Cancer's products in full detail
Stand Up To Cancer's revenues were less than $100M in 2024. All the revenue comes from entertainment rights and distribution.
Subscribe for full access to Stand Up To Cancer's revenue in full detail
Subscribe for full access to Stand Up To Cancer's products in full detail 
